Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimebon in Huntington Disease
NCT00920946Phase 3Completed
- Sponsor
- Medivation
- Start
- Jul 2009
- Primary completion
- Jul 2011
- Modality
- Classical Binding Small Molecules, DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 3 trial of latrepirdine in Huntington disease (HD), sponsored by Medivation. Started Jul 2009; status: completed.
02
Drugs
latrepirdine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT00920946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920946.